Drugs / PPD-S2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01689831 | May → Oct 2012 | tuberculosis | JHP Pharmaceuticals LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PPD-S2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01689831 ↗ |
| Known as | standard tuberculin purified derivative | “Dose comparison study of tuberculin purified protein derivative (PPD)Aplisol with the standard tuberculin purified derivative (PPD-S2).” NCT01689831 ↗ |